These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6548439

  • 1. Extracellular calcium is involved in the mechanism of differentiation of mouse myeloid leukemia cells (M1) induced by 1 alpha, 25-dihydroxyvitamin D3.
    Miyaura C, Abe E, Suda T.
    Endocrinology; 1984 Nov; 115(5):1891-6. PubMed ID: 6548439
    [Abstract] [Full Text] [Related]

  • 2. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption.
    Norman AW, Zhou JY, Henry HL, Uskokovic MR, Koeffler HP.
    Cancer Res; 1990 Nov 01; 50(21):6857-64. PubMed ID: 2208153
    [Abstract] [Full Text] [Related]

  • 3. Treatment of resting zone chondrocytes with 24,25-dihydroxyvitamin D3 [24,25-(OH)2D3] induces differentiation into a 1,25-(OH)2D3-responsive phenotype characteristic of growth zone chondrocytes.
    Schwartz Z, Dean DD, Walton JK, Brooks BP, Boyan BD.
    Endocrinology; 1995 Feb 01; 136(2):402-11. PubMed ID: 7530645
    [Abstract] [Full Text] [Related]

  • 4. Calcium is essential in the fusion of mouse alveolar macrophages induced by 1 alpha,25-dihydroxyvitamin D3.
    Jin CH, Segawa A, Miyaura C, Tanaka H, Abe E, Suda T.
    J Cell Physiol; 1988 Oct 01; 137(1):110-6. PubMed ID: 3139679
    [Abstract] [Full Text] [Related]

  • 5. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
    Abe J, Moriya Y, Saito M, Sugawara Y, Suda T, Nishii Y.
    Cancer Res; 1986 Dec 01; 46(12 Pt 1):6316-21. PubMed ID: 3490908
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
    Kasukabe T, Honma Y, Hozumi M, Suda T, Nishii Y.
    Cancer Res; 1987 Jan 15; 47(2):567-72. PubMed ID: 3466692
    [Abstract] [Full Text] [Related]

  • 10. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
    Koizumi T, Nakao Y, Ishizuka S, Oshida J, Hara N, Ikekawa N, Fijita T.
    Arch Biochem Biophys; 1990 Feb 01; 276(2):310-6. PubMed ID: 2407190
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T, Hino M, Inaba M, Nishizawa Y, Morii H, Otani S.
    Arch Biochem Biophys; 1997 Jul 15; 343(2):181-7. PubMed ID: 9224728
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional defect of variant clones of a human myeloid leukemia cell line (HL-60) resistant to 1 alpha,25-dihydroxyvitamin D3.
    Kuribayashi T, Tanaka H, Abe E, Suda T.
    Endocrinology; 1983 Dec 15; 113(6):1992-8. PubMed ID: 6315339
    [Abstract] [Full Text] [Related]

  • 17. Induction of a high phagocytic capability in P388D1, a macrophage-like tumor cell line, by 1 alpha, 25-dihydroxyvitamin D3.
    Goldman R.
    Cancer Res; 1984 Jan 15; 44(1):11-9. PubMed ID: 6546302
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.
    Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T.
    Proc Natl Acad Sci U S A; 1981 Aug 15; 78(8):4990-4. PubMed ID: 6946446
    [Abstract] [Full Text] [Related]

  • 19. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y, Knutson JC, Bishop C, Shany S.
    Anticancer Res; 1998 Aug 15; 18(3A):1769-75. PubMed ID: 9673403
    [Abstract] [Full Text] [Related]

  • 20. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R.
    Br J Pharmacol; 1997 Mar 15; 120(6):1119-27. PubMed ID: 9134225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.